نتایج جستجو برای: etoposide

تعداد نتایج: 13709  

Journal: :Roczniki Akademii Medycznej w Bialymstoku 2004
A Cierniak M Papiez M Kapiszewska

The aim of the studies was to evaluate the influence of quercetin on etoposide-induced DNA damage in rat bone marrow cells and on changes in the activities of superoxide dismutase (SOD), catalase and antioxidant power in lung tissue (AOP). Quercetin was administrated by gavage at a dose of 135 mg/kg b.w. for three consecutive days, and one hour after the last dose, etoposide was intraperitoneal...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2003
Yuichiro Watanabe Miki Nakajima Noriko Ohashi Toshiyuki Kume Tsuyoshi Yokoi

A metabolite formed by incubation of human liver microsomes, etoposide, and UDP-glucuronic acid was identified as etoposide glucuronide by liquid chromatography-tandem mass spectrometry analysis. According to the derivatization with trimethylsilylimidazole (Tri-Sil-Z), it was confirmed that the glucuronic acid is linked to an alcoholic hydroxyl group of etoposide and not to a phenolic group. Am...

Journal: :Molecular cancer therapeutics 2012
Min-Shao Tsai Shao-Hsing Weng Huang-Jen Chen Yu-Fan Chiu Yu-Ching Huang Sheng-Chieh Tseng Ya-Hsun Kuo Yun-Wei Lin

Etoposide (VP-16), a topoisomerase II inhibitor, is an effective anticancer drug currently used for the treatment of a wide range of cancers. Excision repair cross-complementary 1 (ERCC1) is a key protein involved in the process of nucleotide excision repair. High level of ERCC1 expression in cancers is associated with resistance to DNA damage-based chemotherapy. In this study, the effects of p...

2011
Tooba A. Cheema Ryuichi Kanai Geon Woo Kim Hiroaki Wakimoto Brent Passer Samuel D. Rabkin Robert L. Martuza

Purpose: Glioblastoma (GBM) inevitably recurs despite surgery, radiation, and chemotherapy. A subpopulation of tumor cells, GBM stem cells (GSC), has been implicated in this recurrence. The chemotherapeutic agent etoposide is generally reserved for treating recurrent tumors; however, its effectiveness is limited due to acute and cumulative toxicities to normal tissues. We investigate a novel co...

Journal: :Blood 2009
Judith E Karp Karen Flatten Eric J Feldman Jacqueline M Greer David A Loegering Rebecca M Ricklis Lawrence E Morris Ellen Ritchie B Douglas Smith Valerie Ironside Timothy Talbott Gail Roboz Son B Le Xue Wei Meng Paula A Schneider Nga T Dai Alex A Adjei Steven D Gore Mark J Levis John J Wright Elizabeth Garrett-Mayer Scott H Kaufmann

The farnesyltransferase inhibitor tipifarnib exhibits modest activity against acute myelogenous leukemia. To build on these results, we examined the effect of combining tipifarnib with other agents. Tipifarnib inhibited signaling downstream of the farnesylated small G protein Rheb and synergistically enhanced etoposide-induced antiproliferative effects in lymphohematopoietic cell lines and acut...

Journal: :Biochemical pharmacology 2010
Jean-Philippe Cosse Guillaume Rommelaere Noelle Ninane Thierry Arnould Carine Michiels

Tumor hypoxia is a common characteristic of most solid tumors and is correlated with poor prognosis for patients partly because hypoxia promotes resistance to cancer therapy. Hypoxia selects cancer cells that are resistant to apoptosis and allows the onset of mechanisms that promote cancer cells survival including autophagy. Previously, we showed that human hepatoma HepG2 cells were protected u...

Journal: :Molecular cancer therapeutics 2009
Richard Sullivan Charles H Graham

Intratumoral hypoxia is associated with resistance to therapy in many human cancers, and preexposure of tumor cells to hypoxia confers multidrug resistance. Whereas most anticancer drugs kill proliferating tumor cells by causing DNA damage, a role for hypoxia in the prevention and/or repair of drug-induced DNA damage has not been clear. Using the alkaline comet assay, we provide direct evidence...

Journal: :Cancer research 1987
S Zimm S M Cleary W E Lucas R J Weiss M Markman P A Andrews M A Schiefer S Kim C Horton S B Howell

We administered cisplatin and etoposide by peritoneal dialysis to 39 patients with i.p. malignancies in order to investigate the toxicity, pharmacokinetics, and clinical activity of this 2-drug combination. All patients received i.v. sodium thiosulfate concurrently with the i.p. chemotherapy. Myelosuppression, nausea, vomiting, and malaise were the primary toxicities encountered. The maximum to...

Journal: :Reactions Weekly 2021

Journal: :iranian journal of pharmaceutical research 0
afsaneh zonouzi school of chemistry, university college of science, university of tehran, p.o. box 14155-6455, tehran, iran roghieh mirzazadeh school of chemistry, university college of science, university of tehran, p.o. box 14155-6455, tehran, iran maliheh safavi institute of biochemistry and biophysics, department of biochemistry, university of tehran, tehran, iran sussan k ardestani institute of biochemistry and biophysics, department of biochemistry, university of tehran, tehran, iran saeed emami department of medicinal chemistry and pharmaceutical sciences research center, faculty of pharmacy, mazandaran university of medical sciences, sari, iran. alireza foroumadi 1- faculty of pharmacy and pharmaceutical sciences research center, tehran university of medical sciences, tehran, iran. 2- drug design and development research center, tehran university of medical sciences, tehran, iran.

a series of 2-amino-4-(nitroalkyl)-4h-chromene-3-carbonitriles were synthesized by an efficient multicomponent reaction in aqueous media using dbu (1,8-diazabicyclo[5.4.0]undec-7-ene) as a catalyst at room temperature. mild condition, environment friendly procedure and excellent yields are the main advantages of this procedure. the cytotoxic activity of target compounds were evaluated against t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید